MedPath

A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care

Not Applicable
Completed
Conditions
Colo-rectal Cancer
Interventions
Other: virtual technology - tailored minimally
Other: virtual technology - highly tailored
Registration Number
NCT03407417
Lead Sponsor
University of Florida
Brief Summary

The purpose of this proposal is to test the efficacy of a patient-centered, tailored message intervention delivered via virtual technology for increasing colorectal cancer (CRC) screening within guidelines among racial/ethnic minority and rural patients. This protocol focuses on the clinical portion of grant NCI 1RCA207689-01A1

Detailed Description

Patients (N=3,000) will be recruited via a secure, clinical data warehouse to complete a patient-randomized test of the efficacy of the intervention for promoting initial and repeat FIT testing. Patients identified as eligible will be contacted through MyChart to test a web-based, culturally-sensitive virtual human intervention for CRC screening. The web-application will provide information to encourage CRC screening. Therefore, this study is a minimal risk study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3300
Inclusion Criteria
  • able to read English or Spanish at least at eighth-grade level
  • have an email account or the ability to receive texts
  • willingness to be re-contacted
  • consent to MRR related to CRC screening
  • not remember completing any CRC screening within recommended guidelines (i.e., <10 years for colonoscopy, <1 year for stool test).
  • complete a FIT test:
  • a) with a negative result only
  • b) complete a FIT test with a positive result AND undergo a completion screening colonoscopy,
  • Or c) complete a colonoscopy only.
Read More
Exclusion Criteria
  • unable to read English at least at eighth-grade level
  • doesn't have an email account or the ability to receive texts
  • unwilling to be re-contacted
  • Unable to consent to MRR related to CRC screening
  • have not had <10 years for colonoscopy, or 1 year for stool test
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-FIT testingvirtual technology - tailored minimallyPatients who elected not to have FIT testing after interaction with the application
Fit Testingvirtual technology - highly tailoredPatients who self selected to receive FIT screening after interaction with the Application
Primary Outcome Measures
NameTimeMethod
Completion of initial FIT screeningwithin the first 12 months

Fecal immunochemical test is a screening test for colon cancer. It tests for hidden blood in the stool, which can be an early sign of cancer. FIT only detects human blood from the lower intestines.

Secondary Outcome Measures
NameTimeMethod
Completion of repeat Annual FIT screeningup to 24 months

Fecal immunochemical test is a screening test for colon cancer. It tests for hidden blood in the stool, which can be an early sign of cancer. FIT only detects human blood from the lower intestines.

Trial Locations

Locations (1)

University of Florida

🇺🇸

Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath